With the rising demand for drug-eluting stents, The Global Coronary Stents Market is prognosticated to witness rapid growth in the coming years. In a report, titled, “Coronary Stents Market Size, Share and Global Trend By Deployment (Self and Balloon-expandable), Stent Type (Drug Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent and Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Catheterization Labs) and Geography Forecast till 2025”, Fortune Business Insights identifies various factors enabling growth in the market. As per the report, the global coronary stents market is expected to reach a value of US$ 8,414.5 Mn by 2025, from US$ 5,244.9 Mn in 2017, with a promising CAGR of 6.1%.
Increasing Demand for Self-Expandable Stents to Augment Growth
Manufacturers have introduced next-generation drugs in the drug-eluting stents segment. The widespread distribution of drug-eluting systems around the world is likely to help this segment emerge dominant. In 2017, the drug-eluting stents systems segment accounted for 65.8% share in the market. This segment is also expected to continue dominating the market during the forecast period.
Request Sample PDF:
Similarly, the self-expandable stents segment will show faster growth among other segments based on deployment. This is owing to the expansion of the regional and local markets for coronary stent material across the globe. In addition to this, clinically proven efficiency of self-expandable stents as compared to its counterparts will boost the coronary stents market.
Technological advancements in the coronary stents market, such as error reduction, enhanced workflow, and additional capabilities along with improved accuracy, are helping the market to witness remarkable growth.
Unhealthy Lifestyle and Food Habits, Causing Cardiovascular Disorders, Augmenting Market Growth
Rising geriatric population and their vulnerability towards various diseases are creating the need for medical aids such as coronary stents. Rising prevalence of cardiovascular diseases will also augment the market during the forecast period.
According to the Centre for Disease Control and Prevention, about one-third of the population in the U.S. is obese. The change in lifestyle such as physical inactivity, smoking, drinking,and mistimed and unhealthy food habits are among the major reasons leading to health problems such as obesity, hypertension, arterial blockage, and others.
Such problems further cause vascular disorders and thus fuel the demand for coronary stents. Increasing fatalities due to coronary artery disease has fueled the demand for coronary stents across all health centers and hospitals worldwide.
Browse Complete Report Details:
Price Capping System in India, Propelling Asia Pacific to Emerge as Fastest Growing Market
The presence of a majority of manufacturers in Canada and the U.S. has enabled the North America coronary stent market to e merge dominate. Besides this, the increasing prevalence sedentary lifestyle among people in several developed countries is also fueling demand for coronary stents in the regional market, thus making North America the leading region in the global market. As per Fortune Business Insights, the North America market for coronary stents was valued at US$ 1,616.2 Mn in the year 2017.
It is expected to continue leading the market in the years.Additionally, Asia pacific is anticipated to show rapid growth during the forecast period because of the improved supply chain of coronary stents across pharmacies across hospitals in the region, especially in developing regions of India and China.
In order to improve their accessibility, India has capped prices of coronary stents, and this will be a key factor fueling demand in the long run. Such factors will help the market in Asia Pacific to emerge as the fastest growing region.The competitive landscape of the global coronary stents market is consolidated with top five market players holding a prominent share. These companies are not only investing hugely in research and development but also launching improved products in order to improve their market share post approval.
Some of the key companies operating in the global coronary stents market are Medtronic, Abbott, Terumo Corporation, C. R. Bard, Inc., Cardinal Health, Boston Scientific Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, Cook, and Biotronik SE & Co. KG.
Speak to Analyst:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245